BioSpace News Archive

Pharm Country

Carisma Therapeutics Announces Investor Conference Participation

Carisma Therapeutics Inc. announced that it will be participating in three upcoming investor conferences.

November 16, 2019
·
2 min read
Biotech Beach

Amgen Announces New FOURIER Analysis Showing Benefit Of Repatha® (evolocumab) In High-Risk Patients Who Have Experienced A Recent Heart Attack

Additional FOURIER Analysis Shows Lowering LDL-C With Repatha Did Not Impair Patient-Reported Cognition

November 16, 2019
·
15 min read
Colchicine significantly reduces the risk of first and total ischemic cardiovascular events by 23% and 34% respectively in addition to standard of care in patients with a recent myocardial infarction (MI)

Results simultaneously published in the New England Journal of Medicine and presented at the American Heart Association Late-Breaking Scientific Session

November 16, 2019
·
4 min read
Pharm Country

Janssen Leverages Wearable Technology to Reimagine Clinical Trial Design

CHIEF-HF is the first-ever completely decentralized, mobile, indication-seeking study assessing effectiveness of INVOKANA® (canagliflozin) in adults with heart failure (HF), with or without type 2 diabetes (T2D)

November 16, 2019
·
17 min read
Pharmascience Inc. contributes to the Montreal Heart Institute’s COLchicine Cardiovascular Outcome Trial (COLCOT), a landmark study to benefit cardiovascular patients and the healthcare system

The Montreal Heart Institute announced earlier the results of its COLchicine Cardiovascular Outcomes Trial

November 16, 2019
·
3 min read
Pharm Country

Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019

Single administration of CLBS16 durably improves heart function and symptoms with no cell-related adverse events

November 16, 2019
·
7 min read
Drug Development

Updated Data from Phase 1 ADP-A2M4 Trial Demonstrating Continued Clinical Benefit for People with Synovial Sarcoma

Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, presented updated data from people with synovial sarcoma treated in the ongoing Phase 1 trial with ADP-A2M4.

November 16, 2019
·
4 min read
Pharm Country

The Medicines Company Announces that the ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing

Inclisiran achieved 58% LDL-C lowering with time-adjusted reductions of 56% sustained over 18 months of treatment in patients with atherosclerotic cardiovascular disease (ASCVD)

November 16, 2019
·
9 min read
Drug Development

Kiniksa Presents Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019

Rapid resolution of both reported pain and inflammation as well as improvement in quality of life scores

November 16, 2019
·
13 min read
Pharm Country

ISCHEMIA-CKD Trial: Advanced Chronic Kidney Disease Patients Treated with Invasive Heart Procedures Show No Reduction in Rate of Cardiac Events

Heart disease is the leading cause of death for the roughly 500 million people worldwide with chronic kidney disease Yet such patients have been excluded from most of the major, relevant cardiovascular clinical trials that are meant to guide treatment approaches for them.

November 16, 2019
·
6 min read